Polyphor AG secured its first licensing deal with its proprietary Protein Epitope Mimetic (PEM) technology, an alliance in ophthalmology with Allergan Inc., worth up to $68 million. (BioWorld International) Read More
No Abstract BioWorld International CorrespondentPARIS - Two French biotech firms, Cellectis SA and Genomic Vision SA, have launched a joint project for the development of a revolutionary treatment for HIV and herpes. Read More
No Abstract BioWorld International CorrespondentAvantium Technologies BV raised €18 million (US$23.4 million) in a private financing round to progress its programs in biofuels and drug development and to provide a liquidity event for exiting shareholders. Read More
